Goldman Neal I's Form 4/A amendment
AmendedMilestone Scientific Inc. (MLSS) · filed Oct 11, 2022
- Accession no.
- 0001437749-22-023967
- Filed
- Oct 11, 2022
- Trade date
- Jun 13, 2022
- Filing delay
- 120 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Jun 15, 2022
This filing lists 1 non-derivative transaction. It carries over 1 transaction from the original filing that it did not restate. Open-market purchases total $8.47K. It was filed 120 days after the trade.
This amendment restates part of 0001437749-22-015029 (filed Jun 15, 2022). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Goldman Neal ICIK 0001182567 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 13, 2022 | Common Stock, Par Value $0.001 | AGrant or awardAcquired | +121,951 | $0.82 | +$99,999.82 | 1,272,407 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001437749-22-015029 (filed Jun 15, 2022).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 14, 2022 | Common Stock, Par Value $0.001 | PPurchaseAcquired | +10,583 | $0.80 | +$8,466.4 | 1,180,944 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents the annual fee paid to non-employee directors of $100,000, payable in restricted shares of the Company's common stock valued as of the close of business on the grant date of June 14, 2022, with one-fourth vesting upon the grant and the balance vesting in equal tranches over the next three quarters, October 1, 2022, January 1, 2023, and April 1, 2023.